quinethazone (Compound)

Synonyms:QUINETHAZONE, 73-49-4, Chinethazonum, Hydromox, Quinethazon, Quinethazonum, Aquamox, Idrokin, Chinetazone, Chinetazone [DCIT], Quinetazona [INN-Spanish], Quinethazonum [INN-Latin], 7-chloro-2-ethyl-4-oxo-1,2,3,4-tetrahydroquinazoline-6-sulfonamide, CL 36010, 7-chloro-2-ethyl-4-oxo-2,3-dihydro-1H-quinazoline-6-sulfonamide, QUINETHAZONE (1.5 G), 7-Chloro-2-ethyl-1,2,3,4-tetrahydro-4-oxo-6-quinazolinesulfonamide, NSC-759904, 7-Chloro-2-ethyl-1,2,3,4-tetrahydro-4-oxo-6-sulfamoylquinazoline, 7-Chloro-2-ethyl-6-sulfamoyl-1,2,3,4-tetrahydro-4-quinazolinone, 6-Quinazolinesulfonamide, 7-chloro-2-ethyl-1,2,3,4-tetrahydro-4-oxo-, CHEBI:8717, DTXSID9023548, 455E0S048W, Quinetazona, DTXCID703548, Quinethazone (aquamox), Chinethazone, 2-Ethyl-7-chloro-1,2,3,4-tetrahydro-4-oxoquinazoline-6-sulfonamide, Hydromox (TN), CCRIS 6098, HSDB 3392, EINECS 200-801-7, Quinethazone (JAN/INN), BRN 0818554, UNII-455E0S048W, CAS-73-49-4, 2-Ethyl-7-chloro-1,2,3,4-tetrahydro-4-oxochinazolin-6-sulfonamid, NCGC00016313-01, Quinethazone [USP:INN:BAN:JAN], starbld0009648, Prestwick0_001050, Prestwick1_001050, Prestwick2_001050, Prestwick3_001050, QUINETHAZONE [MI], QUINETHAZONE [INN], QUINETHAZONE [JAN], QUINETHAZONE [HSDB], CHEMBL1532, QUINETHAZONE [VANDF], BSPBio_000980, QUINETHAZONE [MART.], 5-25-09-00214 (Beilstein Handbook Reference), MLS002154126, QUINETHAZONE [WHO-DD], SCHEMBL301310, SPBio_002910, BPBio1_001078, GTPL7289, BDBM25898, HMS1571A22, HMS2098A22, HMS2234O04, HMS3370M01, HMS3715A22, Pharmakon1600-01503877, QUINETHAZONE [ORANGE BOOK], BCP07451, HY-B1364, Tox21_110366, AC8883, MFCD00867329, NSC759904, ZINC00000686, 6-Quinazolinesulfonamide, 1,2,3,4-tetrahydro-7-chloro-2-ethyl-4-oxo-, Tox21_110366_1, CCG-213232, DB01325, NSC 759904, HYDROMOX R COMPONENT QUINETHAZONE, NCGC00179351-03, SMR001233433, SY250224, QUINETHAZONE COMPONENT OF HYDROMOX R, AB00514022, CS-0013105, FT-0674271, C07342, D00461, AB00514022_06, EN300-18568085, SR-01000841190, Q7272222, SR-01000841190-2, BRD-A59303141-001-03-9, 2-Ethyl-7-chloro-2,3-dihydro-4(1H)-quinazolone-6-sulfonamide, 7-chloro-2-ethyl-4-hydroxy-1,2-dihydroquinazoline-6-sulfonamide, 7-Chloro-2-ethyl-1,2,3,4-tetrahydro-4-oxo-6-quinzaolinesulfonamide

Pubchem:PUBCHEM:6307

Id:35f5fd9e-47c9-56cb-9e22-f4149ae948e8

Description:nan

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View quinethazone's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for quinethazone.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with quinethazone.

Results found

Linked to

	Label	Description
	BRD-A59303141-001-10-4 Substance (Entity type)	A Substance
	DCSTRUCT ID 02343 Collection (Entity type)	DrugPage Collection: (DrugCentralID:02343; PubChem_CID:6307, FILE=drugcentral_drug_02343.json)
	quinethazone (1cac42c6-a89f-4f64-aeb3-0c29415fdabf) Collection (Entity type)	Metadatata for quinethazone
	quinethazone negatively regulates PLOD2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	quinethazone negatively regulates MYBPC1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	quinethazone negatively regulates SERINC5 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	quinethazone positively regulates ESR1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	quinethazone positively regulates P2RX5 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	quinethazone positively regulates THBD Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	quinethazone negatively regulates S100P Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS